Microcap Opportunities

Microcap Opportunities

Portfolio Change

Sergio Heiber's avatar
Sergio Heiber
Nov 20, 2025
∙ Paid

Control Bio (CNTB) was added to our portfolio on 8-31-05 at $2.05. We have since changed our strategy to exclude clinical-stage stocks and chasing goal posts, instead focusing on long-term appreciation. Our decision has no bearing on the investment quality for this stock but is strictly a portfolio strategy change. We will record a closeout on CNTB at …

User's avatar

Continue reading this post for free, courtesy of Microcap Opportunities.

Or purchase a paid subscription.
© 2026 MicroCap Opportunities · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture